Continuous Glucose Monitors Without Diabetes: Do You Need One?
OTC continuous glucose monitors are everywhere. Here's what a CGM actually measures, what the evidence shows for people without diabetes, and whether it's worth it.
Manifold Health Clinical Team
Medically reviewed clinical content
Table of contents
Share
Continuous glucose monitors without diabetes: do you need one?
A continuous glucose monitor (CGM) is a small skin-worn sensor that tracks your glucose around the clock, and since 2024 you can buy one over the counter without a prescription. For people with diabetes, CGMs are well-established, guideline-backed tools. For people without diabetes, the honest answer is narrower: a CGM can make your food, movement, and sleep choices visible in a way that sometimes changes behavior, but there is no strong evidence yet that wearing one improves long-term health in people who are metabolically healthy. It's a feedback device, not a diagnostic test — and for most healthy adults it's optional.
The short version
A CGM measures glucose in the fluid just under your skin every few minutes and sends readings to your phone. It doesn't measure blood directly, so readings lag real blood glucose by roughly 5–15 minutes and aren't meant for diagnosing anything.
Since March 2024, the first over-the-counter CGMs — Dexcom's Stelo and Abbott's Lingo — have been available without a prescription for adults not using insulin. They run about $89–$99 a month and are usually not covered by insurance for wellness use.
The evidence splits by purpose. Established: CGMs improve outcomes in diabetes. Emerging: seeing your numbers can nudge helpful diet and activity changes. Contested/unproven: any lasting health benefit for people without diabetes.
Glucose "spikes" after meals are normal, even in very healthy people. A single high reading is not a diagnosis and not a reason to fear a food.
A CGM can be useful if you have prediabetes, are working with a clinician, or want short-term insight into how your body responds to meals. It's worth caution if you have a history of disordered eating or tend to fixate on data.
What a continuous glucose monitor actually measures
A continuous glucose monitor is a coin-sized sensor you wear on the back of your upper arm. A tiny filament sits just under the skin and measures glucose in your interstitial fluid — the fluid surrounding your cells — not in your blood directly. The sensor samples that fluid continuously and sends a reading to your phone every few minutes. Dexcom's Stelo displays a glucose value and trend every 15 minutes and is worn for up to 15 days before replacement, per the FDA's clearance announcement.
That interstitial-fluid detail matters. Because glucose takes time to move from your bloodstream into the surrounding fluid, CGM readings lag actual blood glucose by roughly 5 to 15 minutes, and they lag most during rapid changes — right after a meal or hard exercise. A CGM is excellent at showing trends and patterns over hours and days. It is not a precise, moment-to-moment blood test, and the FDA notes the over-the-counter versions are not designed to detect dangerously low blood sugar.
CGMs sit inside the broader world of remote patient monitoring — connected devices that stream health data to you and, in clinical settings, to your care team. What's new is that the consumer versions cut the clinician out of the loop entirely.
Why so many people without diabetes are wearing one now
Two things changed the market. First, in March 2024 the FDA cleared Dexcom's Stelo as the first over-the-counter continuous glucose monitor — no prescription required — for adults 18 and older who don't use insulin (FDA; Dexcom). Abbott's Lingo followed, cleared as a general wellness tool. Both are now sold online and at major pharmacies for roughly $89–$99 per month, and because they're marketed as wellness products rather than diabetes treatment, insurance generally doesn't cover them (MedTech Dive; GoodRx).
Second, glucose became a wellness story. Market-research firms report that the non-diabetic "wellness" segment is now the fastest-growing group of CGM users, with growth projected at roughly 28–31% per year through the early 2030s (market estimates from Mordor Intelligence, 2026). Those are industry projections, not clinical findings. The result: millions of people who feel fine are now watching their glucose in real time and asking a reasonable question — what do these numbers mean, and do I actually need this?
What the evidence actually shows
Nearly every page that ranks for "best CGM for non-diabetics" is published by a company that sells one. The honest reading of the research is that the evidence depends entirely on who's wearing it and why.
Use case | What the evidence supports | Evidence maturity |
|---|---|---|
Managing diagnosed diabetes | Clear, guideline-backed improvements in glucose control | Established |
Prompting short-term diet and activity changes in people without diabetes | Real-time feedback can nudge behavior; a 2026 meta-analysis found improved average glucose vs. no monitoring | Emerging |
Improving long-term health outcomes in healthy people | Data are scarce and inconsistent; no clear outcome benefit shown | Contested / unproven |
A 2026 systematic review and meta-analysis in the European Journal of Medical Research found that CGM use in non-diabetic participants was associated with improved average glucose compared with not using one, largely by making the effects of food and movement visible and prompting behavior change (Springer, 2026).
But when researchers look for harder health outcomes, the evidence thins fast. Two 2025 systematic reviews on CGM for cardiovascular prevention in non-diabetic individuals concluded the data are too scarce to show any effect on actual cardiovascular outcomes (MDPI Sensors, 2025; PMC 2025). In plain terms: a CGM can change your behavior, and some of those changes may be good for you — but no one has yet shown that wearing one makes a metabolically healthy person live longer or healthier.
Are glucose "spikes" bad if you don't have diabetes?
Short answer: transient glucose rises after meals are completely normal, including in very healthy people. A CGM will show spikes after a bowl of oatmeal or a piece of fruit, and it's easy to misread those as evidence that something is wrong. It usually isn't.
Research using CGMs in people without diabetes has found wide, normal variation in glucose from person to person and day to day — enough that scientists have questioned whether a single reading means much in isolation (Nature Medicine, 2024). The healthiest people tend to have relatively stable glucose overall, but everyone has ups and downs; the pattern over time matters far more than any one peak.
This is where the wellness framing can backfire. Clinicians have raised real concern that constant glucose watching can push some people toward anxiety, food fixation, or restrictive and disordered eating (news-medical.net; VCU Health). There's no such thing as a "bad" food based on a single squiggle on a graph. If tracking numbers makes eating stressful, that's a signal to put the sensor down.
Stelo vs. Lingo vs. a prescription CGM
Stelo (Dexcom) | Lingo (Abbott) | Prescription CGM | |
|---|---|---|---|
Prescription needed | No (OTC) | No (OTC) | Yes |
Intended user | Adults 18+ not on insulin | Adults 18+, general wellness | People with diabetes / on insulin |
Wear time | Up to 15 days | ~14 days | 10–15 days |
Approx. cost | ~$89–$99/month | ~$89/month | Often insured with diagnosis |
Low-glucose alerts | No | No | Yes |
Sources: FDA, MedTech Dive, GoodRx.
The two OTC options are more alike than different: both are feedback tools without hypoglycemia alarms, both cost about the same, and both are designed for insight rather than diagnosis. If you have — or suspect you have — diabetes, that's a conversation for a clinician and a prescription device, not an over-the-counter wellness sensor.
Who might benefit — and who should be cautious
A CGM is most likely worth it if you have prediabetes or a family history of type 2 diabetes and want to see how meals and walks move your glucose (ideally with a clinician), if you're doing a short, curiosity-driven experiment and will act on patterns rather than obsess over peaks, or if you're already working with a provider or dietitian who can put the data in context.
Be cautious — or skip it — if you're metabolically healthy with no risk factors and just chasing "optimization," if you tend to fixate on metrics, or if you have any history of an eating disorder.
When to seek care rather than a sensor: a CGM is not an emergency tool. If you have symptoms like excessive thirst, frequent urination, unexplained weight loss, blurry vision, or episodes of shakiness, sweating, and confusion, don't try to diagnose them with a wellness monitor — see a clinician promptly, and call 911 or go to an emergency room for severe or sudden symptoms.
How to make sense of your readings
A CGM shows you patterns; it doesn't tell you what they mean for your health. If your readings concern you, the numbers that anchor a metabolic evaluation are your HbA1c, which reflects average glucose over about three months, and your fasting insulin, an early marker of how hard your body works to keep glucose in range. Those are the established tools; a CGM is a complement, not a replacement.
Crucially, a CGM cannot diagnose diabetes or prediabetes. Only a clinician can, using validated blood tests interpreted alongside your history. Consistently high readings are a reason to book an appointment — not a diagnosis you can make from an app.
Who to see about your glucose
A primary care physician is the usual starting point and can order and interpret an HbA1c or fasting glucose. An endocrinologist is the specialist for diabetes, prediabetes, and complex metabolic issues. An obesity-medicine physician or registered dietitian can translate glucose patterns into a sustainable plan without fear-based framing. Not sure which fits? See our guide to which doctor you actually need and how to find and choose the right provider. On the clinical side, monitoring devices like CGMs are increasingly built into formal care — see how remote patient monitoring is reimbursed and used by clinicians.
Frequently asked questions
Do non-diabetics need a continuous glucose monitor?
Most healthy adults don't. A CGM can offer useful short-term insight into how your body responds to food and activity, but there's no strong evidence that wearing one improves long-term health in people without diabetes. It's an optional feedback tool, not a necessary test.
Is Stelo or Lingo better?
They're very similar. Both are over-the-counter, cost roughly $89–$99 a month, are worn for about two weeks, and lack low-glucose alerts. The choice usually comes down to app preference and price.
Are glucose spikes bad if you're not diabetic?
No — post-meal glucose rises are normal, even in very healthy people. A single spike is not a diagnosis or a reason to fear a food; the overall pattern over time matters far more.
Does a CGM help you lose weight?
There's no solid evidence that a CGM causes weight loss on its own. For some people the feedback prompts helpful changes, but the device is a tool, not a treatment.
How much does a CGM cost without insurance?
Over-the-counter CGMs run roughly $89–$99 per month, and insurance generally doesn't cover them for wellness use.
Can a CGM diagnose diabetes or prediabetes?
No. Only a clinician can diagnose diabetes or prediabetes using validated blood tests such as HbA1c or fasting glucose. Consistently high CGM readings are a reason to see a provider, not a diagnosis in themselves.
Key takeaways
A CGM measures glucose in the fluid under your skin, not your blood directly, so readings lag and are meant for spotting patterns — not diagnosing anything.
Over-the-counter CGMs (Stelo, Lingo) have been available since 2024 for about $89–$99/month, usually uninsured for wellness use.
The evidence is strong for diabetes, emerging for short-term behavior change, and unproven for long-term health benefit in people without diabetes.
Glucose spikes after meals are normal; the pattern over time matters more than any single reading, and constant tracking carries a real risk of food anxiety for some people.
A CGM can't diagnose anything — interpret concerning readings with a clinician, anchored by standard tests like HbA1c and fasting insulin.
Make sense of your numbers — and find the right care if you need it. If your glucose data or lab results have you wondering what's normal for you, take the free Sidewalk assessment to understand your health and, if warranted, get matched with a provider who can interpret the full picture. Sidewalk helps you navigate to the right care — it doesn't replace it.
This article is for education and is not medical advice. It does not diagnose, treat, or replace care from a qualified professional. A continuous glucose monitor is a wellness tool, not a diagnostic test, and it cannot diagnose diabetes or any other condition. Talk to your clinician about your situation — especially if you have symptoms, a diagnosis, or a history of disordered eating. If you experience severe or sudden symptoms, seek emergency care.
Medically reviewed: pending credentialed medical reviewer sign-off (draft). Author: Manifold Health Clinical Team. Published: July 13, 2026.
